Compare Hims and Hers Health Inc (HIMS) vs Target Corporation (TGT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs Target Corporation — how do they compare? Hims and Hers Health Inc trades at $30.92 (market cap $6.55B), while Target Corporation trades at $153.77 (market cap $70.31B). The key difference: Target Corporation is far larger — about 10.7× Hims and Hers Health Inc's market cap, and Target Corporation pays a 3% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and Target Corporation for 137 Days on average.
| HIMS | TGT | |
|---|---|---|
Market Cap | $6.55B | $70.31B |
Volume | 14,842,814 | 4,164,999 |
Sector | Health | Consumer Staples |
52-Week High | $62.76 | $169.90 |
52-Week Low | $14.52 | $83.68 |
Typical Hold Time | 21 Days | 137 Days |
Enterprise Value | $7.25B | $83.58B |
Dividend Yield | — | 3% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HIMS stock trades at $28.06, down 5.01% on the day, amid a bearish technical signal and negative earnings surprises. The company reported a net loss of $142 million in 2026, with a negative net income margin of -5.51%, despite revenue growth to $2.6 billion. Multiple securities class action lawsuits filed in October 2026 create significant legal overhang, while analyst consensus remains mixed with a $32.17 price target but only 35% buy ratings.
The outlook is clouded by profitability challenges and legal risks, though revenue growth offers a potential catalyst if margins improve. Investors face substantial downside risk from ongoing litigation and weak earnings, offset by analyst price targets suggesting modest upside from current levels if operational execution improves.
Target Corporation (TGT) trades at $154.76, up 2.52% today, with strong earnings momentum after beating expectations for three consecutive quarters. The stock shows bearish technical signals but maintains solid fundamentals with a 26.41% ROE and 4.08% net margin. Recent price cuts on 2,000 items aim to capture holiday market share, while analyst consensus remains balanced with a $167.18 price target suggesting 8% upside potential.
Target presents a mixed investment case with strong profitability metrics and consistent dividend payments offset by bearish technical indicators and competitive retail pressures. The company's turnaround strategy shows early signs of traction, but execution risks and margin pressures from aggressive pricing remain key concerns for investors seeking exposure to the retail sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About Target Corporation
With 1,926 stores (as of the end of fiscal 2021), Target is a leading American general merchandise retailer, offering a variety of products across several categories, including beauty and household essentials (26% of fiscal 2021 sales), food and beverage (19%), home furnishings and décor (19%), hardlines (18%), and apparel and accessories (17%). Most of Target's stores are large, averaging more than 125,000 square feet. The company has a significant e-commerce presence, deriving around 19% of sales from the channel (up from about 9% in fiscal 2019, before the pandemic). In addition to its namesake stores, Target owns Shipt, an online same-day delivery platform. After it exited Canada in 2015, virtually all of Target's revenue is generated from the United States.
Read more on TGT →
